Q-202

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameQ-202
Drug Alias Namebreast cancer antibody (QUE Oncology/University of Queensland)Q-202
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionCalcium release-activated calcium channel protein 1 modulators
TargetsCalcium release-activated calcium channel protein 1
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of Queensland
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A